Related Experiment Video
Updated: Dec 25, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
COVID-19 Infection in a Patient with End-Stage Kidney Disease
Dian Fu1,2, Bo Yang3, Jing Xu4
1Department of Urology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Insights
COVID-19 patients with end-stage kidney disease (ESKD) require isolation dialysis. Continuous renal replacement therapy (CRRT) benefited one such patient by stabilizing his condition and aiding recovery.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic poses significant risks to patients with end-stage kidney disease (ESKD).
- ESKD patients with COVID-19 often require specialized renal replacement therapy, such as continuous renal replacement therapy (CRRT).
- Limited availability of CRRT machines presents a challenge in managing these critical patients.
Observation:
- A case study of a 75-year-old male with ESKD and COVID-19 infection is presented.
- The patient required isolation dialysis due to his comorbidities.
- Continuous renal replacement therapy (CRRT) was initiated for this patient.
Findings:
- CRRT effectively removed toxins, stabilizing the patient's metabolic and hemodynamic status.
- Management of uremia and fluid balance was achieved through CRRT.
- The patient experienced an uneventful recovery, with symptom resolution and negative PCR tests post-CRRT.
Implications:
- CRRT can be a beneficial intervention for COVID-19 patients with ESKD.
- Addressing the limited availability of CRRT machines is crucial for improving outcomes.
- Further efforts are needed to reduce mortality rates in this vulnerable patient population.
Abstract:
Since December 2019, the epidemic of coronavirus disease 2019 (COVID-19) has spread very rapidly in China and worldwide. In this article, we report on a 75-year-old man infected with 2019 novel coronavirus who has end-stage kidney disease (ESKD). COVID-19 patients with ESKD need isolation dialysis, but most of them cannot be handled in time due to limited continuous renal replacement therapy (CRRT) machines. CRRT provided benefits for this patient by removing potentially damaging toxins and stabilizing his metabolic and hemodynamic status. With the control of uremia and fluid status, this patient ended up with an uneventful post-CRRT course, absence of clinical symptoms, and negative PCR tests. Greater efforts are needed to decrease the mortality of COVID-19-infected ESKD patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management

